Jovanny Zabaleta

The paper identifies three TNBC subtypes based on spatial transcriptomics and cellular mapping, revealing distinct tumor microenvironment architectures and potential therapeutic targets.

This study uses spatial transcriptomics to identify molecular and cellular differences between good and poor prognosis triple-negative breast cancer subtypes, revealing distinct gene signatures that could inform therapy.

This paper identifies three subtypes of TNBC based on transcriptomic profiles and cell-type composition, linking them to potential therapeutic targets and clinical outcomes.